首页> 美国卫生研究院文献>Blood research >Organ-specific considerations for marginal zone lymphomas in Korea based on Consortium for Improving Survival of Lymphoma (CISL) and Korean clinical studies

【2h】

Organ-specific considerations for marginal zone lymphomas in Korea based on Consortium for Improving Survival of Lymphoma (CISL) and Korean clinical studies

机译：基于提高淋巴瘤生存率的联合会（CISL）和韩国临床研究对韩国边缘区淋巴瘤的器官特定考虑因素

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Blood research
作者
Sung Yong Oh; Cheolwon Suh;
展开▼
作者单位

展开▼
年(卷),期 2019(54),1
年度 2019
页码 4–6
总页数 3
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Waldeyer's ring marginal zone B cell lymphoma: Are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL) [J] . International journal of hematology . 2012,第5期

机译：Waldeyer环边缘B细胞淋巴瘤：临床和预后特征是淋巴结还是淋巴结外？联合会改善淋巴瘤生存率的研究（CISL）
2. Waldeyer’s ring marginal zone B cell lymphoma: are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL) [J] . Sung Yong Oh, Won Seog Kim, Jin Seok Kim, International Journal of Hematology . 2012,第5期

机译：Waldeyer的环状边缘B细胞淋巴瘤：是淋巴结还是淋巴结外的临床和预后特征？联合会改善淋巴瘤生存率的研究（CISL）
3. Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial [J] . Yoo Kwai Han, Lee Hyewon, Suh Cheolwon International journal of hematology . 2018,第4期

机译：韩国淋巴瘤流行病学和实际临床领域，包括联盟，用于改善淋巴瘤（CISL）试验的存活
4. CD180: a new Marginal Zone B-cell Lymphoma biomarker discovered by plasma membrane microparticle proteomic analysis [C] . Sarah Lennon, Laurent Miguet, Christine Carapito, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2013

机译：CD180：血浆膜微粒蛋白质组学分析发现的新边缘区B细胞淋巴瘤生物标志物
5. Understanding the Most Frequently Experienced Barriers to the Adherence of Lymphoma Clinical Practice Guidelines (CPGs) and Their Effect on the Lymphoma Physicians' Utilization of CPGs: An Explanatory Mixed-Methods Study [D] . Munteanu, Mihaela Catalina 2018

机译：了解淋巴瘤临床实践指南（CPG）遵守的最常遇到的障碍及其对淋巴瘤医师使用CPG的影响：解释性混合方法研究
6. Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study [O] . Sung Yong Oh, Won Seog Kim, Jin Seok Kim, 2019

机译：晚期边缘区淋巴瘤患者的R–CVP II期研究和利妥昔单抗维持治疗：联合会提高淋巴瘤生存率（CISL）研究
7. Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial [O] . Kwai Han Yoo, Hyewon Lee, Cheolwon Suh 2018

机译：韩国淋巴瘤流行病学和实际临床领域，包括改善淋巴瘤的存活（CISL）试验的联盟

Organ-specific considerations for marginal zone lymphomas in Korea based on Consortium for Improving Survival of Lymphoma (CISL) and Korean clinical studies

著录项

相似文献

相关主题

期刊订阅